| Subject: | Important Information Regarding Institutional Review Board Registration with the FDA |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Thu, 3 Sep 2009 - 06:00 am |
| The Food and Drug Administration (FDA) is informing institutional review boards (IRB) that if they review FDA-regulated research and have not submitted an initial registration or provided the FDA-specific information required by FDA's new IRB Registration Rule in the modified Office for Human Research Protections (OHRP) database since July 14, 2009, then they are not registered with FDA. IRBs that have not previously registered in the OHRP database may do so using the new IRB... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
External Links:
|
|
StayAlert! provides immediate notification of regulatory body legislation impacting the healthcare industry, helping you to meet regulatory compliance. Subscribers are notified of any new or revised regulations, provided with a summary of the regulation, followed by an implementation action plan and/or policy. Designed as an e-mail "push" method for rapid customer notification of healthcare compliance issues, paired with interpretative analysis and practical application, the StayAlert!® Virtual Compliance Administrator™ saves you time and money. Other vendors have components of legislated requirements available online or on CD-ROM. However there is no other product that marries regulatory agency mandates with implementation tools, making the latest compliance information immediately available online. No other product provides an interpretative analysis, followed by a practical application tool, therefore providing users with an immediate solution to compliance problems. StayAlert! includes operational components for healthcare organizations, allowing complete facility compliance with mandated requirements, online. |
|
